Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial. Hernandez-Cardenas C, Thirion-Romero I, Rodriguez-Llamazares S, Rivera-Martinez NE, et al. PLoS One 2021;16:e0257238.

Read + Share

Amedeo Smart

Independent Medical Education

Hernandez-Cardenas C, Thirion-Romero I, Rodriguez-Llamazares S, Rivera-Martinez NE, et al. Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial. PLoS One 2021;16:e0257238.
PMID: 34582477